Ulrike Wehkamp

Ulrike Wehkamp

Arnold Heller Str. 3
Kiel, SH 24105, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network.

Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network.

Journal: Cancers

Published: November 27, 2025

Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a truly 'benign' disease?

Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a truly 'benign' disease?

Journal: The British journal of dermatology

Published: September 28, 2025

A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification.

A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification.

Journal: Blood

Published: April 16, 2025

Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis.

Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: February 28, 2025

European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.

European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.

Journal: The British journal of dermatology

Published: January 25, 2025

Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

Journal: The Lancet. Haematology

Published: October 24, 2024

Chlormethine Gel for Treatment of Patients with Mycosis Fungoides: Best Practices and Guidance to Clinicians.

Chlormethine Gel for Treatment of Patients with Mycosis Fungoides: Best Practices and Guidance to Clinicians.

Journal: Dermatology and therapy

Published: September 18, 2024

Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients.

Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients.

Journal: Experimental dermatology

Published: January 31, 2024

Stage-related increase in PIM2 expression in mycosis fungoides.

Stage-related increase in PIM2 expression in mycosis fungoides.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: December 18, 2023

Expert opinions and clinical experiences with chlormethine gel as maintenance treatment for patients with mycosis fungoides.

Expert opinions and clinical experiences with chlormethine gel as maintenance treatment for patients with mycosis fungoides.

Journal: Frontiers in medicine

Published: September 22, 2023

Mycosis fungoides: differentiation from inflammation and detection of circulating tumour cells with the EuroClonality next-generation sequencing assay.

Mycosis fungoides: differentiation from inflammation and detection of circulating tumour cells with the EuroClonality next-generation sequencing assay.

Journal: The British journal of dermatology

Published: September 03, 2023

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 05, 2023

Showing 1-12 of 69

Last Updated: 09/26/2026